US6605712B1
(en)
|
1990-12-20 |
2003-08-12 |
Arch Development Corporation |
Gene transcription and ionizing radiation: methods and compositions
|
US5807270A
(en)
*
|
1994-06-20 |
1998-09-15 |
Williams; Christopher Edward |
Brain damage monitor
|
GB9524968D0
(en)
*
|
1995-12-06 |
1996-02-07 |
Brown Brian H |
Impedance pneumography
|
WO1998036686A1
(fr)
*
|
1997-02-24 |
1998-08-27 |
Tanita Corporation |
Instrument de mesure de l'impedance d'un corps vivant et instrument de mesure de la composition d'un corps
|
ES2142219B1
(es)
*
|
1997-03-06 |
2000-11-16 |
Nte Sa |
Procedimiento para determinar la composicion y calidad de sustancias de naturaleza carnica.
|
ES2151774B1
(es)
*
|
1997-03-06 |
2001-07-01 |
Nte Sa |
Aparato y procedimiento para la medida de volumenes y composicion corporal global y segmental en seres humanos.
|
ES2143911B1
(es)
*
|
1997-03-06 |
2000-12-01 |
Nte Sa |
Metodo y aparato para medir la concentracion y composicion de biomasa.
|
JP3125730B2
(ja)
*
|
1997-09-11 |
2001-01-22 |
憲一 山越 |
血行動態表示装置
|
US6153811A
(en)
|
1997-12-22 |
2000-11-28 |
Dekalb Genetics Corporation |
Method for reduction of transgene copy number
|
US6125297A
(en)
*
|
1998-02-06 |
2000-09-26 |
The United States Of America As Represented By The United States National Aeronautics And Space Administration |
Body fluids monitor
|
US6122544A
(en)
*
|
1998-05-01 |
2000-09-19 |
Organ; Leslie William |
Electrical impedance method and apparatus for detecting and diagnosing diseases
|
US6307123B1
(en)
|
1998-05-18 |
2001-10-23 |
Dekalb Genetics Corporation |
Methods and compositions for transgene identification
|
US6429357B1
(en)
|
1999-05-14 |
2002-08-06 |
Dekalb Genetics Corp. |
Rice actin 2 promoter and intron and methods for use thereof
|
AUPQ113799A0
(en)
*
|
1999-06-22 |
1999-07-15 |
University Of Queensland, The |
A method and device for measuring lymphoedema
|
US6387671B1
(en)
*
|
1999-07-21 |
2002-05-14 |
The Regents Of The University Of California |
Electrical impedance tomography to control electroporation
|
WO2001028416A1
(en)
|
1999-09-24 |
2001-04-26 |
Healthetech, Inc. |
Physiological monitor and associated computation, display and communication unit
|
JP3705574B2
(ja)
*
|
1999-09-30 |
2005-10-12 |
株式会社タニタ |
生体電気インピーダンス測定装置
|
US7499745B2
(en)
*
|
2000-02-28 |
2009-03-03 |
Barbara Ann Karmanos Cancer Institute |
Multidimensional bioelectrical tissue analyzer
|
US6482158B2
(en)
|
2000-05-19 |
2002-11-19 |
Healthetech, Inc. |
System and method of ultrasonic mammography
|
US6607387B2
(en)
|
2000-10-30 |
2003-08-19 |
Healthetech, Inc. |
Sensor system for diagnosing dental conditions
|
JP4124649B2
(ja)
*
|
2000-11-29 |
2008-07-23 |
株式会社フィジオン |
身体組成測定方法及び身体組成測定装置
|
US6768921B2
(en)
*
|
2000-12-28 |
2004-07-27 |
Z-Tech (Canada) Inc. |
Electrical impedance method and apparatus for detecting and diagnosing diseases
|
FI109651B
(fi)
|
2001-03-23 |
2002-09-30 |
Delfin Technologies Ltd |
Menetelmä kudosturvotuksen mittaamiseksi
|
US8034791B2
(en)
|
2001-04-06 |
2011-10-11 |
The University Of Chicago |
Activation of Egr-1 promoter by DNA damaging chemotherapeutics
|
ES2184609B1
(es)
*
|
2001-04-27 |
2004-06-16 |
Nte S.A. |
Metodo y aparato de obtencion de caracteristicas fisicas y/o quimicas de un medio biologico.
|
EP1399541A4
(en)
|
2001-05-22 |
2005-04-13 |
Univ Chicago |
RNA POLYMERASE DEPENDENT ON SINGLE VIBRATION N4 DNA
|
IL143374A0
(en)
*
|
2001-05-24 |
2002-04-21 |
Transscan Medical Ltd |
Anomaly detection based on signal variations
|
WO2002100247A2
(en)
*
|
2001-06-13 |
2002-12-19 |
Ckm Diagnostics, Inc. |
Non-invasive method and apparatus for tissue detection
|
EP1450605B1
(en)
|
2001-10-26 |
2011-12-07 |
Baylor College Of Medicine |
Composition to alter bone properties in a subject
|
MY142457A
(en)
|
2001-12-11 |
2010-11-30 |
Advisys Inc |
Plasmid mediated supplementation for treating chronically ill subjects
|
US8211031B2
(en)
*
|
2002-01-15 |
2012-07-03 |
Orsan Medical Technologies Ltd. |
Non-invasive intracranial monitor
|
US7998080B2
(en)
*
|
2002-01-15 |
2011-08-16 |
Orsan Medical Technologies Ltd. |
Method for monitoring blood flow to brain
|
AU2003209608A1
(en)
|
2002-01-15 |
2003-07-30 |
Orsan Medical Equipment Ltd. |
Device for monitoring blood flow to brain
|
JP4105472B2
(ja)
*
|
2002-04-12 |
2008-06-25 |
株式会社フィジオン |
身体組成測定装置
|
ES2542420T3
(es)
|
2002-05-22 |
2015-08-05 |
Monsanto Technology Llc |
Desaturasas de ácidos grasos de hongos
|
US6916474B2
(en)
|
2002-07-15 |
2005-07-12 |
Board Of Regents, The University Of Texas System |
Antibodies with increased affinities for anthrax antigens
|
EP2269618A1
(en)
|
2002-08-12 |
2011-01-05 |
Jennerex Biotherapeutics ULC |
An oncolytic vaccinia virus for use in combination with a chemotherapy for treating cancer.
|
AU2002951925A0
(en)
*
|
2002-10-09 |
2002-10-24 |
Queensland University Of Technology |
An Impedence Cardiography Device
|
US20030126593A1
(en)
*
|
2002-11-04 |
2003-07-03 |
Mault James R. |
Interactive physiological monitoring system
|
EP2557164A1
(en)
|
2003-02-18 |
2013-02-13 |
Kevin M. Slawin |
Induced activation in dendritic cells
|
US20060264775A1
(en)
*
|
2003-03-14 |
2006-11-23 |
Mills Gary N |
Methods of and apparatus for determining fluid volume presence in mammalian tissue
|
WO2004091390A2
(en)
|
2003-04-15 |
2004-10-28 |
Philips Intellectual Property & Standards Gmbh |
Device and method for examination and use of an electrical field in an object under examination containing magnetic particles
|
DE10339084B4
(de)
*
|
2003-08-26 |
2015-10-29 |
Drägerwerk AG & Co. KGaA |
Elektroimpedanztomographie-Gerät
|
CN101926647B
(zh)
*
|
2003-09-12 |
2013-06-05 |
肾脏研究所有限公司 |
生物阻抗方法和仪器
|
US20080076998A1
(en)
*
|
2003-12-01 |
2008-03-27 |
Z-Tech (Canada) Inc. |
Breast electrode array and method of analysis for detecting and diagnosing diseases
|
WO2005065090A2
(en)
*
|
2003-12-30 |
2005-07-21 |
The Mitre Corporation |
Techniques for building-scale electrostatic tomography
|
WO2005122888A1
(en)
|
2004-06-18 |
2005-12-29 |
The University Of Queensland |
Oedema detection
|
US8068906B2
(en)
|
2004-06-21 |
2011-11-29 |
Aorora Technologies Pty Ltd |
Cardiac monitoring system
|
JP4904263B2
(ja)
*
|
2004-07-15 |
2012-03-28 |
オーサン メディカル テクノロジーズ リミテッド |
脳灌流監視装置
|
US20060085048A1
(en)
*
|
2004-10-20 |
2006-04-20 |
Nervonix, Inc. |
Algorithms for an active electrode, bioimpedance-based tissue discrimination system
|
WO2006044868A1
(en)
*
|
2004-10-20 |
2006-04-27 |
Nervonix, Inc. |
An active electrode, bio-impedance based, tissue discrimination system and methods and use
|
EP2287303B1
(en)
|
2004-11-12 |
2014-07-02 |
Asuragen, Inc. |
Methods and compositions involving miRNA and miRNA inhibitor molecules
|
US8103337B2
(en)
|
2004-11-26 |
2012-01-24 |
Impedimed Limited |
Weighted gradient method and system for diagnosing disease
|
US8109981B2
(en)
*
|
2005-01-25 |
2012-02-07 |
Valam Corporation |
Optical therapies and devices
|
DE102005022896B3
(de)
*
|
2005-05-18 |
2006-05-11 |
Dräger Medical AG & Co. KG |
Vorrichtung und Verfahren zur Steuerung eines Beatmungsgerätes
|
CA2609111C
(en)
|
2005-07-01 |
2016-10-18 |
Scott Chetham |
A method and apparatus for performing impedance measurements in accordance with determining an electrode arrangement using a displayed representation
|
AU2006265761B2
(en)
*
|
2005-07-01 |
2011-08-11 |
Impedimed Limited |
Monitoring system
|
AU2006265762B2
(en)
*
|
2005-07-01 |
2012-08-16 |
Impedimed Limited |
Pulmonary monitoring system
|
EP1909642A1
(en)
*
|
2005-07-20 |
2008-04-16 |
Impedance Cardiology Systems Inc. |
Index determination
|
US8099250B2
(en)
*
|
2005-08-02 |
2012-01-17 |
Impedimed Limited |
Impedance parameter values
|
KR20090004839A
(ko)
|
2005-09-07 |
2009-01-12 |
제네렉스, 인코포레이티드 |
Gm-csf를 발현하는 폭스바이러스를 사용한 전이성및/또는 전신 파종성 암의 전신 치료법
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
EP1948017B1
(en)
|
2005-10-11 |
2014-04-02 |
Impedimed Limited |
Hydration status monitoring
|
EP2368570A3
(en)
|
2006-01-18 |
2012-05-02 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
US7794404B1
(en)
|
2006-03-31 |
2010-09-14 |
Pacesetter, Inc |
System and method for estimating cardiac pressure using parameters derived from impedance signals detected by an implantable medical device
|
US8600497B1
(en)
|
2006-03-31 |
2013-12-03 |
Pacesetter, Inc. |
Systems and methods to monitor and treat heart failure conditions
|
CA2653406C
(en)
*
|
2006-05-30 |
2015-03-17 |
The University Of Queensland |
Impedance measurements
|
ATE543097T1
(de)
|
2006-07-27 |
2012-02-15 |
Univ Maryland |
Zellulärer rezeptor für antiproliferativen faktor
|
US8481023B2
(en)
|
2006-09-15 |
2013-07-09 |
Ottawa Hospital Research Institute |
Oncolytic rhabdovirus
|
AU2007310946B2
(en)
|
2006-10-19 |
2014-06-05 |
Baylor College Of Medicine |
Generating an immune response by inducing CD40 and pattern recognition receptors
|
EP2087096A4
(en)
|
2006-10-20 |
2009-11-25 |
Univ Arizona |
MODIFIED CYANOBACTERIA
|
US9504406B2
(en)
|
2006-11-30 |
2016-11-29 |
Impedimed Limited |
Measurement apparatus
|
US8067179B2
(en)
|
2006-11-30 |
2011-11-29 |
Research Development Foundation |
Immunoglobulin libraries
|
WO2008086565A1
(en)
*
|
2007-01-15 |
2008-07-24 |
Impedimed Limited |
Monitoring system
|
KR20080084528A
(ko)
|
2007-03-15 |
2008-09-19 |
제네렉스 바이오테라퓨틱스 인크. |
종양살상형 백시니아 바이러스 암 치료
|
EP2137589B1
(en)
*
|
2007-03-30 |
2015-02-25 |
Impedimed Limited |
Active guarding for reduction of resistive and capacitive signal loading with adjustable control of compensation level
|
US8504153B2
(en)
|
2007-04-04 |
2013-08-06 |
Pacesetter, Inc. |
System and method for estimating cardiac pressure based on cardiac electrical conduction delays using an implantable medical device
|
US8208999B2
(en)
|
2007-04-04 |
2012-06-26 |
Pacesetter, Inc. |
System and method for estimating electrical conduction delays from immittance values measured using an implantable medical device
|
JP5419861B2
(ja)
*
|
2007-04-20 |
2014-02-19 |
インぺディメッド リミテッド |
インピーダンス測定装置および方法
|
US8629245B2
(en)
|
2007-05-01 |
2014-01-14 |
Research Development Foundation |
Immunoglobulin Fc libraries
|
US7596411B1
(en)
|
2007-06-08 |
2009-09-29 |
Pacesetter, Inc. |
Apparatus and method for two-component bioelectrical impedance ratio measuring and monitoring
|
US20110046505A1
(en)
*
|
2007-08-09 |
2011-02-24 |
Impedimed Limited |
Impedance measurement process
|
EP2666784B1
(en)
|
2007-08-31 |
2017-04-05 |
University Of Chicago |
Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
|
AU2008324750B2
(en)
*
|
2007-11-05 |
2014-01-16 |
Impedimed Limited |
Impedance determination
|
US9605035B2
(en)
|
2008-01-10 |
2017-03-28 |
Research Development Foundation |
Vaccines and diagnostics for the ehrlichioses
|
DK2245464T3
(en)
|
2008-01-25 |
2017-02-20 |
Multivir Inc |
P53 BIOMARKETS
|
WO2009096821A1
(en)
*
|
2008-01-29 |
2009-08-06 |
St.Jude Medical Ab |
Method and implantable medical device (imd) for monitoring permeability status of cell membranes.
|
AU2008207672B2
(en)
*
|
2008-02-15 |
2013-10-31 |
Impedimed Limited |
Impedance Analysis
|
KR101871192B1
(ko)
|
2008-06-04 |
2018-06-27 |
후지필름 셀룰러 다이내믹스, 인코포레이티드 |
비-바이러스 접근법을 사용한 iPS 세포의 생산 방법
|
CN102171348A
(zh)
|
2008-08-12 |
2011-08-31 |
细胞动力国际有限公司 |
产生ips细胞的方法
|
EP2328603A4
(en)
|
2008-08-18 |
2013-01-02 |
Univ Maryland |
APF DERIVATIVES AND USE METHOD
|
EP2331680B1
(en)
|
2008-09-22 |
2017-05-03 |
Baylor College Of Medicine |
Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters
|
CN102333540B
(zh)
|
2008-10-06 |
2015-04-22 |
芝加哥大学 |
与细菌eap、emp和/或adsa蛋白相关的组合物和方法
|
EP2344034B1
(en)
*
|
2008-10-07 |
2015-09-30 |
Orsan Medical Technologies Ltd. |
Monitoring of acute stroke patients
|
GB0820309D0
(en)
*
|
2008-11-06 |
2008-12-17 |
Middlesex University Higher Ed |
Detection of cancer
|
JP5616900B2
(ja)
|
2008-11-28 |
2014-10-29 |
インぺディメッド リミテッドImpedimed Limited |
インピーダンス測定処理
|
JP5651125B2
(ja)
|
2008-12-10 |
2015-01-07 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
Mek阻害剤に対する耐性を付与するmek突然変異
|
EP2379720B1
(en)
|
2009-01-20 |
2016-08-17 |
Alona Zilberberg |
Mir-21 promoter driven targeted cancer therapy
|
US8764672B2
(en)
*
|
2009-02-17 |
2014-07-01 |
Preston K. Manwaring |
System, method and device for monitoring the condition of an internal organ
|
US20120058523A1
(en)
|
2009-02-17 |
2012-03-08 |
Edenspace Systems Corporation |
Tempering of cellulosic biomass
|
AU2010271116B2
(en)
|
2009-04-03 |
2015-08-13 |
University Of Chicago |
Compositions and methods related to Protein A (SpA) variants
|
WO2010129347A2
(en)
|
2009-04-28 |
2010-11-11 |
Vanderbilt University |
Compositions and methods for the treatment of disorders involving epithelial cell apoptosis
|
WO2010138971A1
(en)
|
2009-05-29 |
2010-12-02 |
Edenspace Systems Corporation |
Plant gene regulatory elements
|
CN103087991B
(zh)
|
2009-06-05 |
2018-06-12 |
富士胶片细胞动力公司 |
重编程t细胞和造血细胞的方法
|
US20110053803A1
(en)
|
2009-08-26 |
2011-03-03 |
Xin Ge |
Methods for creating antibody libraries
|
DK2477499T3
(en)
|
2009-09-14 |
2018-06-06 |
Sillajen Biotherapeutics Inc |
COMBINATION CANCER THERAPY WITH ONCOLYTIC VACCINIA VIRUS
|
WO2011050271A1
(en)
|
2009-10-23 |
2011-04-28 |
Monsanto Technology Llc |
Methods and compositions for expression of transgenes in plants
|
WO2011050393A1
(en)
|
2009-10-26 |
2011-05-05 |
Impedimed Limited |
Fluid level indicator determination
|
JP5755234B2
(ja)
|
2009-11-18 |
2015-07-29 |
インぺディメッド リミテッドImpedimed Limited |
患者−電極間測定のための装置およびシステム
|
AU2010329551B2
(en)
|
2009-12-10 |
2016-02-11 |
Turnstone Limited Partnership |
Oncolytic rhabdovirus
|
US10080799B2
(en)
|
2010-02-12 |
2018-09-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
BR112012021411A2
(pt)
|
2010-02-25 |
2017-04-18 |
Dana Farber Cancer Inst Inc |
mutações braf que conferem resistência a inibidores braf.
|
WO2011108930A1
(en)
|
2010-03-04 |
2011-09-09 |
Interna Technologies Bv |
A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT
|
ES2714875T3
(es)
|
2010-03-09 |
2019-05-30 |
Dana Farber Cancer Inst Inc |
Métodos de diagnóstico y tratamiento del cáncer en pacientes que presentan o desarrollan resistencia a una primera terapia del cáncer
|
US8808699B2
(en)
|
2010-04-05 |
2014-08-19 |
The University Of Chicago |
Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response
|
WO2011126976A1
(en)
|
2010-04-07 |
2011-10-13 |
Vanderbilt University |
Reovirus vaccines and methods of use therefor
|
WO2011133512A1
(en)
|
2010-04-19 |
2011-10-27 |
Research Development Foundation |
Rtef-1 variants and uses thereof
|
AU2011255481B2
(en)
|
2010-05-19 |
2014-09-11 |
The Samuel Roberts Noble Foundation, Inc. |
Altered leaf morphology and enhanced agronomic properties in plants
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
EA028080B1
(ru)
|
2010-06-09 |
2017-10-31 |
Дана-Фарбер Кэнсер Инститьют, Инк. |
Мутация в mek1, придающая устойчивость к ингибиторам raf и mek
|
WO2011159797A2
(en)
|
2010-06-15 |
2011-12-22 |
Cellular Dynamics International, Inc. |
A compendium of ready-built stem cell models for interrogation of biological response
|
ES2670842T3
(es)
|
2010-06-15 |
2018-06-01 |
Cellular Dynamics International, Inc. |
Generación de células madre pluripotentes inducidas a partir de pequeños volúmenes de sangre periférica
|
ES2655701T3
(es)
|
2010-07-02 |
2018-02-21 |
The University Of Chicago |
Composiciones y métodos relacionados con variantes de la proteína A (SpA)
|
WO2012005572A1
(en)
|
2010-07-06 |
2012-01-12 |
Interna Technologies Bv |
Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
|
CA2804595C
(en)
|
2010-07-07 |
2018-11-13 |
Cellular Dynamics International, Inc. |
Endothelial cell production by programming
|
JP5936218B2
(ja)
|
2010-08-04 |
2016-06-22 |
セルラー ダイナミクス インターナショナル, インコーポレイテッド |
不死化b細胞のリプログラミング
|
JP5793194B2
(ja)
|
2010-09-09 |
2015-10-14 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
感染防御ブドウ球菌抗原が関与する方法および組成物
|
US9084746B2
(en)
|
2010-09-22 |
2015-07-21 |
The Regents Of The University Of Colorado, A Body Corporate |
Therapeutic applications of SMAD7
|
WO2012061615A1
(en)
|
2010-11-03 |
2012-05-10 |
The Samuel Roberts Noble Foundation, Inc. |
Transcription factors for modification of lignin content in plants
|
JP6121910B2
(ja)
|
2011-01-04 |
2017-04-26 |
シラジェン バイオセラピューティクス インコーポレイテッド |
腫瘍溶解性ワクシニアウイルスの投与による腫瘍抗原に対する抗体の生成および腫瘍特異的補体依存性細胞傷害の生成
|
EP2474617A1
(en)
|
2011-01-11 |
2012-07-11 |
InteRNA Technologies BV |
Mir for treating neo-angiogenesis
|
EP2673299B1
(en)
|
2011-02-07 |
2017-05-10 |
Research Development Foundation |
Engineered immunoglobulin fc polypeptides
|
EP2673358B1
(en)
|
2011-02-08 |
2019-01-09 |
FUJIFILM Cellular Dynamics, Inc. |
Hematopoietic precursor cell production by programming
|
US9307918B2
(en)
|
2011-02-09 |
2016-04-12 |
Orsan Medical Technologies Ltd. |
Devices and methods for monitoring cerebral hemodynamic conditions
|
EP3406628A1
(en)
|
2011-04-08 |
2018-11-28 |
Evaxion Biotech ApS |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
EP2718427B1
(en)
|
2011-06-08 |
2017-01-11 |
Children's Hospital of Eastern Ontario Research Institute Inc. |
Compositions for glioblastoma treatment
|
WO2013009825A1
(en)
|
2011-07-11 |
2013-01-17 |
Cellular Dynamics International, Inc. |
Methods for cell reprogramming and genome engineering
|
CA2845259A1
(en)
|
2011-08-15 |
2013-02-21 |
The University Of Chicago |
Compositions and methods related to antibodies to staphylococcal protein a
|
WO2013026015A1
(en)
|
2011-08-18 |
2013-02-21 |
Dana-Farber Cancer Institute, Inc. |
Muc1 ligand traps for use in treating cancers
|
WO2013053899A1
(en)
|
2011-10-12 |
2013-04-18 |
Moeller Niels Iversen |
Peptides derived from campylobacter jejuni and their use in vaccination
|
WO2013090798A1
(en)
|
2011-12-14 |
2013-06-20 |
Intersection Medical, Inc. |
Devices, systems and methods for determining the relative spatial change in subsurface resistivities across frequencies in tissue
|
ES2886147T3
(es)
|
2011-12-22 |
2021-12-16 |
Interna Tech B V |
MiARN para el tratamiento del cáncer de cabeza y de cuello
|
CN104114087B
(zh)
*
|
2012-02-15 |
2017-09-26 |
皇家飞利浦有限公司 |
生物阻抗摄谱系统和方法
|
CA2910320A1
(en)
|
2012-04-26 |
2013-10-31 |
University Of Chicago |
Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
|
ES2806945T3
(es)
|
2012-04-26 |
2021-02-19 |
Univ Chicago |
Antígenos de coagulasa estafilocócica y métodos para su uso
|
JP6371765B2
(ja)
|
2012-07-31 |
2018-08-08 |
ザ・ボード・オブ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・テキサス・システムThe Board Of Regents Of The University Of Texas System |
糖尿病治療用医薬組成物
|
PT2897454T
(pt)
|
2012-09-24 |
2020-01-09 |
Seminis Vegetable Seeds Inc |
Métodos e composições para prolongamento da vida útil de produtos vegetais
|
US9890216B2
(en)
|
2012-10-23 |
2018-02-13 |
Board Of Regents, The University Of Texas System |
Antibodies with engineered IgG Fc domains
|
WO2014072357A1
(en)
|
2012-11-06 |
2014-05-15 |
Interna Technologies B.V. |
Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated b-raf pathway
|
WO2014116721A1
(en)
|
2013-01-22 |
2014-07-31 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
ES2741147T3
(es)
|
2013-02-21 |
2020-02-10 |
Turnstone Lp |
Composición de vacuna
|
US20140242595A1
(en)
|
2013-02-22 |
2014-08-28 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
DE102013203177A1
(de)
|
2013-02-26 |
2014-08-28 |
Hamilton Medical Ag |
System zur automatisierten Einstellung eines durch eine Beatmungseinrichtung vorgegebenen Drucks
|
US10086093B2
(en)
|
2013-02-28 |
2018-10-02 |
The General Hospital Corporation |
miRNA profiling compositions and methods of use
|
WO2014132137A2
(en)
|
2013-03-01 |
2014-09-04 |
Université De Genève |
Transgenic cell selection
|
CN105358704B
(zh)
|
2013-03-08 |
2020-01-03 |
科罗拉多大学董事会 |
Ptd-smad7治疗剂
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
CA2905352A1
(en)
|
2013-03-14 |
2014-09-25 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlling t cell proliferation
|
DK3004329T3
(da)
|
2013-06-05 |
2020-05-18 |
Bellicum Pharmaceuticals Inc |
Fremgangsmåder til induktion af delvis apoptose under anvendelse af caspasepolypeptider
|
AU2014317861B2
(en)
|
2013-09-09 |
2019-11-28 |
Figene, Llc |
Gene therapy for the regeneration of chondrocytes or cartilage type cells
|
EP3065706A4
(en)
|
2013-11-08 |
2017-11-29 |
Baylor Research Institute |
Nuclear localization of glp-1 stimulates myocardial regeneration and reverses heart failure
|
CA2965327C
(en)
|
2013-11-08 |
2023-05-09 |
The Board Of Regents Of The University Of Texas System |
Vh4 antibodies against gray matter neuron and astrocyte
|
EP4227685A3
(en)
|
2013-12-03 |
2024-02-28 |
Evaxion Biotech A/S |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
EP3099719B1
(en)
|
2014-01-29 |
2020-04-01 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against the muc1-c/extracellular domain (muc1-c/ecd)
|
US10214741B2
(en)
|
2014-02-14 |
2019-02-26 |
University Of Utah Research Foundation |
Methods and compositions for inhibiting retinopathy of prematurity
|
JP6772063B2
(ja)
|
2014-02-14 |
2020-10-21 |
ベリカム ファーマシューティカルズ, インコーポレイテッド |
誘導可能なキメラポリペプチドを使用して細胞を活性化するための方法
|
US20170037091A1
(en)
|
2014-02-25 |
2017-02-09 |
Research Development Foundation |
Sty peptides for inhibition of angiogenesis
|
US20170107486A1
(en)
|
2014-04-21 |
2017-04-20 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
CA2959168A1
(en)
|
2014-09-02 |
2016-03-10 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by myd88 and cd40 polypeptides
|
JP6718444B2
(ja)
|
2014-11-03 |
2020-07-08 |
アカデミッシュ ザイケンホイス レイデン (エイチ.オー.ディー.エヌ. エルユーエムシー) |
Bob1に対して指向されるT細胞レセプターおよびその使用
|
EP3218002B1
(en)
|
2014-11-13 |
2020-08-19 |
Evaxion Biotech ApS |
Peptides derived from acinetobacter baumannii and their use in vaccination
|
EP3608408A1
(en)
|
2014-12-15 |
2020-02-12 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlled activation or elimination of therapeutic cells
|
US10434162B2
(en)
|
2015-01-12 |
2019-10-08 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniae
|
US20180002656A1
(en)
|
2015-01-28 |
2018-01-04 |
Sabic Global Technologies B.V. |
Methods and compositions for high-efficiency production of biofuel and/or biomass
|
US10457737B2
(en)
|
2015-02-09 |
2019-10-29 |
Research Development Foundation |
Engineered immunoglobulin Fc polypeptides displaying improved complement activation
|
WO2016134293A1
(en)
|
2015-02-20 |
2016-08-25 |
Baylor College Of Medicine |
p63 INACTIVATION FOR THE TREATMENT OF HEART FAILURE
|
JP2018510627A
(ja)
|
2015-03-10 |
2018-04-19 |
レイデン ユニバーシティ メディカル センター |
メラノーマ優先発現抗原に対して向けられたt細胞レセプターおよびその使用
|
EP4116316A1
(en)
|
2015-07-04 |
2023-01-11 |
Evaxion Biotech A/S |
Proteins and nucleic acids useful in vaccines targeting pseudomonas aeruginosa
|
WO2017040380A2
(en)
|
2015-08-28 |
2017-03-09 |
Research Development Foundation |
Engineered antibody fc variants
|
JP6976939B2
(ja)
|
2015-10-20 |
2021-12-08 |
フジフィルム セルラー ダイナミクス,インコーポレイテッド |
遺伝的プログラミングによる多系統造血前駆細胞の作製
|
US11154573B2
(en)
|
2015-10-30 |
2021-10-26 |
The Regents Of The University Of California |
Methods of generating T-cells from stem cells and immunotherapeutic methods using the T-cells
|
ES2892972T3
(es)
|
2015-11-02 |
2022-02-07 |
Univ Texas |
Métodos de activación de CD40 y bloqueo de punto de control inmunitario
|
EP3371221A2
(en)
|
2015-11-07 |
2018-09-12 |
MultiVir Inc. |
Methods and compositions comprising tumor suppressor gene therapy and immune checkpoint blockade for the treatment of cancer
|
JP6987068B2
(ja)
|
2015-11-09 |
2021-12-22 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアThe Children’S Hospital Of Philadelphia |
癌マーカーおよび治療標的としてのグリピカン2
|
GB2545703B
(en)
|
2015-12-22 |
2019-01-09 |
Univ Sheffield |
Apparatus and methods for determining force applied to the tip of a probe
|
US10946084B2
(en)
|
2016-02-22 |
2021-03-16 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus
|
US20190177391A1
(en)
|
2016-03-31 |
2019-06-13 |
Baylor Research Institute |
Angiopoietin-like protein 8 (angptl8)
|
WO2017216384A1
(en)
|
2016-06-17 |
2017-12-21 |
Evaxion Biotech Aps |
Vaccination targeting ichthyophthirius multifiliis
|
WO2017220787A1
(en)
|
2016-06-24 |
2017-12-28 |
Evaxion Biotech Aps |
Vaccines against aearomonas salmonicida infection
|
JP7099967B2
(ja)
|
2016-07-01 |
2022-07-12 |
リサーチ ディベロップメント ファウンデーション |
幹細胞由来移植片からの増殖性細胞の排除
|
US11414464B2
(en)
|
2016-07-22 |
2022-08-16 |
Evaxion Biotech A/S |
Chimeric proteins for inducing immunity towards infection with S. aureus
|
US9963498B2
(en)
|
2016-08-18 |
2018-05-08 |
Wisconsin Alumni Research Foundation |
Peptides that inhibit syndecan-1 activation of VLA-4 and IGF-1R
|
CA3039136A1
(en)
|
2016-09-02 |
2018-03-08 |
The Regents Of The University Of California |
Methods and compositions involving interleukin-6 receptor alpha-binding single chain variable fragments
|
US10961505B2
(en)
|
2016-10-05 |
2021-03-30 |
FUJIFILM Cellular Dynamics, Inc. |
Generating mature lineages from induced pluripotent stem cells with MECP2 disruption
|
JP7212615B2
(ja)
|
2016-10-05 |
2023-01-25 |
フジフィルム セルラー ダイナミクス,インコーポレイテッド |
多能性幹細胞からhlaホモ接合免疫細胞への指向分化方法
|
JP2020510624A
(ja)
|
2016-12-12 |
2020-04-09 |
マルチビア インコーポレイテッド |
がんおよび感染性疾患の治療および予防のための、ウイルス遺伝子治療および免疫チェックポイント阻害剤を含む方法および組成物
|
EP3565576A1
(en)
|
2017-01-05 |
2019-11-13 |
Evaxion Biotech ApS |
Vaccines targeting pseudomonas aeruginosa
|
WO2018195175A1
(en)
|
2017-04-18 |
2018-10-25 |
FUJIFILM Cellular Dynamics, Inc. |
Antigen-specific immune effector cells
|
US20210147507A1
(en)
|
2017-05-09 |
2021-05-20 |
Bellicum Pharmaceuticals, Inc. |
Methods to augment or alter signal transduction
|
EP3704250A1
(en)
|
2017-11-03 |
2020-09-09 |
InteRNA Technologies B.V. |
Mirna molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
|
US11612618B2
(en)
|
2017-11-14 |
2023-03-28 |
Henry Ford Health System |
Compositions for use in the treatment and prevention of cardiovascular disorders resulting from cerebrovascular injury
|
BR112020013715A2
(pt)
|
2018-01-05 |
2020-12-01 |
Ottawa Hospital Research Institute |
vetores de vaccinia modificados
|
WO2019145399A1
(en)
|
2018-01-24 |
2019-08-01 |
Evaxion Biotech Aps |
Vaccines for prophylaxis of s. aureus infections
|
WO2020036635A2
(en)
|
2018-03-19 |
2020-02-20 |
Multivir Inc. |
Methods and compositions comprising tumor suppressor gene therapy and cd122/cd132 agonists for the treatment of cancer
|
CA3133899A1
(en)
|
2018-03-30 |
2019-10-03 |
University Of Geneva |
Micro rna expression constructs and uses thereof
|
US20220000932A1
(en)
|
2018-09-28 |
2022-01-06 |
Henry Ford Health System |
Use of extracellular vesicles in combination with tissue plasminogen activator and/or thrombectomy to treat stroke
|
EP3870207A1
(en)
|
2018-10-22 |
2021-09-01 |
Evaxion Biotech ApS |
Vaccines targeting m. catharrhalis
|
WO2020171889A1
(en)
|
2019-02-19 |
2020-08-27 |
University Of Rochester |
Blocking lipid accumulation or inflammation in thyroid eye disease
|
EP3931206A1
(en)
|
2019-02-27 |
2022-01-05 |
Evaxion Biotech ApS |
Vaccines targeting h. influenzae
|
WO2020212756A2
(en)
|
2019-04-18 |
2020-10-22 |
Genkin Dmitry Dmitrievich |
Reprogramming of polymorphonuclear leukocytes
|
WO2021016062A1
(en)
|
2019-07-19 |
2021-01-28 |
The Children's Hospital Of Philadelphia |
Chimeric antigen receptors containing glypican 2 binding domains
|
TW202128160A
(zh)
|
2019-10-18 |
2021-08-01 |
美國加利福尼亞大學董事會 |
用於治療病原性血管病症之方法及組合物
|
WO2021113644A1
(en)
|
2019-12-05 |
2021-06-10 |
Multivir Inc. |
Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer
|
US20230050225A1
(en)
|
2020-01-06 |
2023-02-16 |
Evaxion Biotech A/S |
Vaccines targeting Neisseria gonorrhoeae
|
CA3179599A1
(en)
|
2020-05-27 |
2021-12-02 |
Marco ALESSANDRINI |
Adapter molecules to re-direct car t cells to an antigen of interest
|
MX2022015012A
(es)
|
2020-05-29 |
2023-03-03 |
Fujifilm Cellular Dynamics Inc |
Epitelio pigmentado de retina y agregados de celulas duales fotorreceptoras y metodos de uso de los mismos.
|
JP2023536210A
(ja)
|
2020-05-29 |
2023-08-24 |
フジフィルム セルラー ダイナミクス,インコーポレイテッド |
網膜色素上皮及び光受容体の二重層、並びにその使用
|
AU2021401052A1
(en)
|
2020-12-18 |
2023-06-22 |
Century Therapeutics, Inc. |
Chimeric antigen receptor systems with adaptable receptor specificity
|
JP2024508088A
(ja)
|
2021-02-09 |
2024-02-22 |
ユニバーシティ オブ ヒューストン システム |
全身送達及び抗腫瘍活性の向上のための腫瘍溶解性ウイルス
|
EP4294445A1
(en)
|
2021-02-19 |
2023-12-27 |
Pfizer Inc. |
Methods of protecting rna
|
JP2024513453A
(ja)
|
2021-04-08 |
2024-03-25 |
ヤンセン バイオテツク,インコーポレーテツド |
増強された幹細胞様メモリーt細胞操作のための材料及び方法
|
KR20240005837A
(ko)
|
2021-05-03 |
2024-01-12 |
아스텔라스 인스티튜트 포 리제너러티브 메디슨 |
성숙한 각막 내피 세포의 생성 방법
|
WO2022235869A1
(en)
|
2021-05-07 |
2022-11-10 |
Astellas Institute For Regenerative Medicine |
Methods of generating mature hepatocytes
|
EP4347796A1
(en)
|
2021-05-26 |
2024-04-10 |
Fujifilm Cellular Dynamics, Inc. |
Methods to prevent rapid silencing of genes in pluripotent stem cells
|
CN117915944A
(zh)
|
2021-07-05 |
2024-04-19 |
伊沃逊生物科技股份公司 |
靶向淋病奈瑟氏菌的疫苗
|
WO2023081813A1
(en)
|
2021-11-05 |
2023-05-11 |
St. Jude Children's Research Hospital, Inc. |
Zip cytokine receptors
|
WO2023081894A2
(en)
|
2021-11-08 |
2023-05-11 |
St. Jude Children's Research Hospital, Inc. |
Pre-effector car-t cell gene signatures
|
WO2023089556A1
(en)
|
2021-11-22 |
2023-05-25 |
Pfizer Inc. |
Reducing risk of antigen mimicry in immunogenic medicaments
|
GB2614309A
(en)
|
2021-12-24 |
2023-07-05 |
Stratosvir Ltd |
Improved vaccinia virus vectors
|
WO2023144779A1
(en)
|
2022-01-28 |
2023-08-03 |
Pfizer Inc. |
Coronavirus antigen variants
|
US20230295661A1
(en)
|
2022-03-16 |
2023-09-21 |
University Of Houston System |
Persistent hsv gene delivery system
|
WO2023213393A1
(en)
|
2022-05-04 |
2023-11-09 |
Evaxion Biotech A/S |
Staphylococcal protein variants and truncates
|
GB202206507D0
(en)
|
2022-05-04 |
2022-06-15 |
Antion Biosciences Sa |
Expression construct
|
WO2023240109A1
(en)
|
2022-06-07 |
2023-12-14 |
Regeneron Pharmaceuticals, Inc. |
Multispecific molecules for modulating t-cell activity, and uses thereof
|
WO2023240182A1
(en)
|
2022-06-08 |
2023-12-14 |
St. Jude Children's Research Hospital, Inc. |
Disruption of kdm4a in t cells to enhance immunotherapy
|
US20240010742A1
(en)
|
2022-06-10 |
2024-01-11 |
Research Development Foundation |
Engineered fcriib selective igg1 fc variants and uses thereof
|
US20240003871A1
(en)
|
2022-06-29 |
2024-01-04 |
FUJIFILM Cellular Dynamics, Inc. |
Ipsc-derived astrocytes and methods of use thereof
|
WO2024059787A1
(en)
|
2022-09-16 |
2024-03-21 |
St. Jude Children's Research Hospital, Inc. |
Disruption of asxl1 in t cells to enhance immunotherapy
|